TY - JOUR
T1 - Bioorthogonal Chemistry Enables Single-Molecule FRET Measurements of Catalytically Active Protein Disulfide Isomerase
AU - Chinnaraj, Mathivanan
AU - Barrios, David A.
AU - Frieden, Carl
AU - Heyduk, Tomasz
AU - Flaumenhaft, Robert
AU - Pozzi, Nicola
N1 - Funding Information:
The authors are grateful to Dr. Edward Lemke for providing the plasmid pEvol PylRS used to incorporate Prk into human recombinant PDI. This work was supported in part by President's Research Fund, Saint Louis University and grants R01 HL150146 (N.P.) and R01 HL125275, T32 HL007917, and R35 HL135775 (R.F.) from the National Heart, Lung and Blood Institute.
Publisher Copyright:
© 2020 Wiley-VCH GmbH
PY - 2021/1/5
Y1 - 2021/1/5
N2 - Folding of newly synthesized proteins in the endoplasmic reticulum is assisted by several families of enzymes. One such family is the protein disulfide isomerases (PDIs). PDIs are oxidoreductases, capable of forming new disulfide bonds or breaking existing ones. Structural information on PDIs unbound and bound to substrates is highly desirable for developing targeted therapeutics, yet it has been difficult to obtain by using traditional approaches because of their relatively large size and remarkable flexibility. Single-molecule FRET (smFRET) could be a powerful tool to study PDIs’ structure and dynamics under conditions relevant to physiology, but its implementation has been hindered by technical challenges of position-specific fluorophore labeling. We have overcome this limitation by site-specifically engineering fluorescent dyes into human PDI, the founding member of the family. Proof-of-concept smFRET measurements of catalytically active PDI demonstrate, for the first time, the feasibility of this approach, expanding the toolkit for structural studies of PDIs.
AB - Folding of newly synthesized proteins in the endoplasmic reticulum is assisted by several families of enzymes. One such family is the protein disulfide isomerases (PDIs). PDIs are oxidoreductases, capable of forming new disulfide bonds or breaking existing ones. Structural information on PDIs unbound and bound to substrates is highly desirable for developing targeted therapeutics, yet it has been difficult to obtain by using traditional approaches because of their relatively large size and remarkable flexibility. Single-molecule FRET (smFRET) could be a powerful tool to study PDIs’ structure and dynamics under conditions relevant to physiology, but its implementation has been hindered by technical challenges of position-specific fluorophore labeling. We have overcome this limitation by site-specifically engineering fluorescent dyes into human PDI, the founding member of the family. Proof-of-concept smFRET measurements of catalytically active PDI demonstrate, for the first time, the feasibility of this approach, expanding the toolkit for structural studies of PDIs.
KW - FRET
KW - click chemistry
KW - oxidoreductases
KW - single-molecule studies
KW - structural biology
UR - http://www.scopus.com/inward/record.url?scp=85091603770&partnerID=8YFLogxK
U2 - 10.1002/cbic.202000537
DO - 10.1002/cbic.202000537
M3 - Article
C2 - 32857455
AN - SCOPUS:85091603770
SN - 1439-4227
VL - 22
SP - 134
EP - 138
JO - ChemBioChem
JF - ChemBioChem
IS - 1
ER -